StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJun 16, 2026, 05:06 PM

CEL-SCI Raises $2.5M via Common Stock Offering

AI Summary

CEL-SCI Corporation announced the closing of a best-efforts offering, selling 2,500,000 shares of its common stock at $1.00 per share. This transaction generated gross proceeds of $2.5 million, before deducting placement agent fees and offering expenses. The company intends to utilize the net proceeds to fund the continued development of Multikine, for general corporate purposes, and working capital. ThinkEquity LLC acted as the sole placement agent for the offering.

Key Highlights

  • CEL-SCI Corporation closed a best-efforts offering of 2,500,000 shares of common stock.
  • The shares were sold at an offering price of $1.00 per share.
  • The offering generated gross proceeds of $2,500,000.
  • The Company will pay ThinkEquity LLC a 7.0% cash fee and up to $67,000 for expenses.
  • Net proceeds will fund Multikine development, general corporate purposes, and working capital.
  • The Company agreed to a 30-day lock-up on further equity issuance.
  • Directors and officers are subject to a 45-day lock-up on selling company securities.